Cargando…
Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
Opana (oxymorphone) is a powerful semi-synthetic opioid agonist used for chronic pain management that is ingested orally. However, improper injection of Opana can lead to a rare and fatal blood disorder known as thrombotic microangiopathy. Opana-induced thrombotic microangiopathy can be easily mista...
Autores principales: | Ban, Byung H., Verma, Ashish, Tudor, Maria, Sethi, Jigme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451891/ https://www.ncbi.nlm.nih.gov/pubmed/28580158 http://dx.doi.org/10.1093/omcr/omx026 |
Ejemplares similares
-
Opana(®) ER induced thrombotic thrombocytopenic purpura
por: Kotbi, Nabil, et al.
Publicado: (2015) -
Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER
por: Thakur, Kamia, et al.
Publicado: (2017) -
COVID‐19‐induced thrombotic microangiopathy: A great mimicker of thrombotic thrombocytopenic purpura (TTP)
por: Warnecke, Brian, et al.
Publicado: (2023) -
Opana ER (Oxymorphone)–Induced Thrombotic Microangiopathy: An Atypical Presentation in a Patient With Hepatitis C
por: Mehmood, Hassan, et al.
Publicado: (2018) -
Thrombotic Thrombocytopenic Purpura (TTP)–Like Illness Associated with Intravenous Opana ER Abuse — Tennessee, 2012
por: Marder, Ellyn, et al.
Publicado: (2013)